Introducing the new PEPperCHIP® Cancer Neoepitope Microarrays at the AACR

PEPperCHIP® Cancer Neoepitope Microarray

We invite you to meet us at the AACR Annual Meeting 2017 on April 1-5, 2017 in the exhibition area at booth #3548 in Washington, D.C.

At the AACR, PEPperPRINT will introduce the new PEPperCHIP® Cancer Neoepitope Microarray for the fingerprint analysis of cancer antibody responses against tumor neoepitopes.


The new PEPperCHIP® Cancer Neoepitope Microarray enables you to:

  • translate cancer point mutations into peptide microarrays
  • switch from sequencing data to a personalized peptide microarray in 4 weeks
  • validate therapeutic antibodies against tumor associated antigens
  • identify immunogenic neoepitopes for immunotherapy
  • develop individualized cancer vaccines
  • monitor personalized antibody responses
  • discover prognostic cancer neoepitopes


Join our representative Carsten Haber at booth #3548 to learn more about our solutions for cancer research, and particularly about our new PEPperCHIP® Cancer Neoepitope Microarrays.

We look forward to meet you there!


Download product flyer here!